NCT07680972

Brief Summary

Antimicrobial resistance genes (ARGs) are the genes that allow bacteria to survive antibiotic treatments. These genes can be found in beneficial gut microbes, and occur more frequently in infants than adults. These genes can also transmit between different bacterial species. Exclusively breastfed infants carry fewer ARGs than formula fed infants. We are trying to find out if care-givers working with exclusively breastfed infants have fewer ARGs than those working with formula fed infants.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
34mo left

Started Aug 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 2, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 20, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2027

1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2029

Last Updated

July 2, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

June 26, 2026

Last Update Submit

June 26, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Count of antimicrobial resistance genes (ARGs) in stool

    Count of ARGs in stool sample, and association with infant usual diet

    2 weeks from enrollment

  • Abundance of antimicrobial resistance genes (ARGs)

    Abundance of ARGs in stool samples from caregivers in relation to infant usual feeding practices

    2 weeks from enrollment

Secondary Outcomes (3)

  • Count and diversity of antimicrobial resistance genes (ARGs) and caregiver diet

    2 weeks from enrollment

  • Diversity and abundance of antimicrobial resistance genes (ARGs) and interactions

    2 weeks

  • Caregiver gut microbiome

    2 weeks

Interventions

We will collect stool samples and questionnaires on infant caregivers

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Professional infant caregivers who work with infants at least 3 days a week for at least 6 hours per day who meet the inclusion and exclusion criteria of the sample.

You may qualify if:

  • Employment at a childcare facility or home daycare at time of sampling
  • Participant works and interacts with infants under the age 6 months old, including responsibility for changing diapers
  • Participant \>18 years old

You may not qualify if:

  • Participant has a history or presence of a medical condition including Ulcerative Colitis, Crohn's Disase, Inflammatory Bowel Disease, colon cancer, Celiac's disease, or other GI disordrs
  • Current priobitic use or probiotic use within the last 4 weeks
  • Participant is currently pregnant or breastfeeding
  • Participant has an infant \<12 months old at home for 3 or more days per week
  • Enrollment in a clinical trial involving an invstigational drug or dvic
  • Antibiotic use within the past 3 months
  • Participant working exclusively with infants \>6 months old at time of stool sample collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Diana H Taft, PhD

CONTACT

Dylan KP Blaufus, MS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2026

First Posted

July 2, 2026

Study Start (Estimated)

August 20, 2026

Primary Completion (Estimated)

August 19, 2027

Study Completion (Estimated)

May 31, 2029

Last Updated

July 2, 2026

Record last verified: 2026-06